FPR2 agonist 3
FPR2 agonist 3 (compound CMC23) can limit the lactate dehydrogenase release in LPS -stimulated cultures and decrease the levels of pro-inflammatory IL-1β and IL-6. FPR2 agonist 3 decrease the level of phosphor-STAT3 via the STAT3/SOCS3 signaling pathway[1].
Product Specifications
CAS Number
2829263-19-4
UNSPSC
12352005
Target
Formyl Peptide Receptor (FPR)
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/fpr2-agonist-3.html
Purity
99.39
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
FC1=CC=C(NC(N[C@@H](CC2=CC=C(C#N)C=C2)C(N3C(C=C(F)C=C4)=C4CC3)=O)=O)C=C1
Molecular Formula
C25H20F2N4O2
Molecular Weight
446.45
References & Citations
[1]Jie Zang, et al. Targeting NOX2 with Bivalent Small-Molecule p47phox-p22phox Inhibitors. J Med Chem. 2023.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Glycerophosphoric Acid Sodium Salt Hydate, Racemic
![1-Benzo[b]thien-4-yl-piperazine Monohydrochloride](https://cdn.genprice.uk/products/572/1120552832115/imageurl/trc-b194840-5g.webp)
1-Benzo[b]thien-4-yl-piperazine Monohydrochloride
